Stem cells are your body’s raw materials, the cells from which all other specialized cells are generated. They have two defining abilities that no other cell type shares: they can copy themselves indefinitely (a process called self-renewal), and they can mature into specialized cell types like blood cells, brain cells, muscle cells, or bone cells. Every tissue repair job your body performs, from healing a cut to replacing worn-out blood cells, depends on stem cells doing this work.
How Stem Cells Differ From Other Cells
Most cells in your body have a fixed identity and a limited lifespan. A red blood cell carries oxygen for about 120 days, then dies and gets replaced. A skin cell lives for two to three weeks. These specialized cells generally cannot divide to make new copies of themselves, and they cannot transform into a different cell type.
Stem cells break both of those rules. When a stem cell divides, it can produce either another stem cell (maintaining the supply) or a more specialized cell that goes on to perform a specific job. This branching choice is what makes stem cells so valuable to the body and so interesting to medicine. The signals that push a stem cell toward one fate or the other come from its surrounding environment: neighboring cells, chemical signals, physical contact with structural proteins, and even mechanical forces like stiffness and pressure.
The Potency Spectrum
Not all stem cells are equally versatile. Scientists rank them by “potency,” which describes how many different cell types they can produce.
- Totipotent cells can become any cell in the body plus the cells that form the placenta. The only undisputed totipotent cell is the fertilized egg, or zygote.
- Pluripotent cells can become any cell type in the adult body but cannot form placental tissue. Embryonic stem cells fall into this category.
- Multipotent cells can produce several cell types, but only within a related family. Blood-forming stem cells in your bone marrow, for example, generate red blood cells, white blood cells, and platelets, but they cannot make brain cells or muscle cells.
The further down this spectrum a stem cell sits, the more restricted its options. Your body contains mostly multipotent stem cells, tucked into specific tissues where they quietly maintain and repair their local neighborhood.
Three Main Sources
Embryonic Stem Cells
These are harvested from early-stage embryos (typically three to five days old) and are pluripotent, meaning they can develop into virtually any cell type. Their extraordinary flexibility makes them powerful research tools, but their origin raises ethical questions that have shaped regulations worldwide. Most countries follow a guideline, first proposed in 1984, that limits growing human embryos in the lab to no more than 14 days.
Adult (Somatic) Stem Cells
Adult stem cells exist throughout your body. They’ve been identified in bone marrow, fat tissue, the lining of the intestines, skin, the brain, and many other organs. These cells are multipotent, serving as a built-in repair system for the tissue they live in. The best-known example is the blood-forming stem cell in bone marrow, which produces the entire range of blood and immune cells your body needs daily.
Induced Pluripotent Stem Cells (iPSCs)
In 2006, Japanese researcher Shinya Yamanaka discovered that ordinary adult cells, like skin cells, could be reprogrammed back into a pluripotent state by activating just four specific genes. These reprogrammed cells, called iPSCs, behave much like embryonic stem cells but can be made from a patient’s own tissue. That sidesteps both the ethical concerns of using embryos and the risk of immune rejection during treatment.
How Stem Cells Actually Heal
For years, researchers assumed stem cells repaired damaged tissue simply by replacing dead or injured cells with fresh ones. That does happen, but it turns out to be only part of the story. Studies on heart repair have shown that when stem cells are injected into damaged cardiac tissue, very few of them actually transform into new heart muscle cells. The numbers are far too small to explain the improvements in heart function that researchers observe.
Instead, stem cells appear to do most of their healing by releasing chemical signals into the surrounding tissue. These signals trigger several protective responses: they encourage the growth of new blood vessels to restore blood supply, reduce harmful inflammation, help remodel scar tissue, and protect nearby cells from dying. Think of stem cells less as replacement parts and more as project managers that coordinate the repair crew already on site. This signaling-based repair mechanism is now considered the primary way stem cell therapies improve outcomes in heart disease research and likely plays a role in other tissues as well.
The Stem Cell Niche
Stem cells don’t float freely through your body. Each population lives in a highly specific microenvironment called a niche. In bone marrow, the niche includes blood vessel cells, immune cells, and a dense network of structural proteins that physically anchor stem cells in place. Neighboring cells send chemical signals that keep stem cells in a dormant, quiet state until they’re needed.
When injury or disease disrupts this balance, new signals wake the stem cells up and push them to divide and differentiate. The niche also deteriorates with age. In muscle tissue, for instance, aging niches begin releasing growth signals that prematurely pull stem cells out of their resting state, eventually depleting the supply and reducing the muscle’s ability to regenerate. This age-related decline in niche quality is one reason wounds heal more slowly and tissues recover less completely as you get older.
Current Approved Treatments
Despite the enormous promise of stem cell science, only one type of stem cell therapy is routinely approved by the FDA: blood stem cell transplantation (commonly known as bone marrow transplant). It is used to treat cancers and disorders that affect the blood and immune system, including leukemia, lymphoma, and certain inherited blood disorders like sickle cell disease. Tens of thousands of these transplants are performed worldwide each year.
Beyond that single proven application, nearly everything else you might see advertised as “stem cell therapy” is either experimental or unregulated. Clinical trials are actively testing new uses. The National Eye Institute, for example, is running a first-in-human trial using iPSC-derived cells to treat advanced dry macular degeneration, a leading cause of vision loss. In this trial, researchers create a tiny patch of retinal cells from a patient’s own reprogrammed skin cells and surgically place it beneath the retina. The patch takes about six months to manufacture, and participants are followed for five years. The trial’s primary goal is safety, not vision improvement, which underscores how early-stage most stem cell treatments still are.
The Ethical Landscape
Stem cell research sits at the intersection of biology, medicine, and ethics. The central tension involves embryonic stem cells, since harvesting them destroys the embryo. Different countries have drawn very different lines. The United States prohibits federal funding for research that creates or modifies human embryos with heritable genetic changes. The United Kingdom became the first country in 2015 to approve mitochondrial replacement therapy, a technique involving embryo modification. Regulations on egg donation, embryo research, and human-animal hybrid experiments vary widely between nations and even between states.
The International Society for Stem Cell Research (ISSCR) publishes guidelines meant to supplement local laws and push toward global consensus, but significant gaps remain, particularly around transplanting human stem cells into animal models. The development of iPSCs has eased some of these debates by offering a path to pluripotent cells without using embryos, though questions about cloning, genetic modification, and creating human-animal chimeras continue to evolve alongside the science.